These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3122798)

  • 1. Effect of chronic valproic acid treatment on plasma and urine carnitine levels in children: decreased urinary excretion.
    Melegh B; Kerner J; Kispál G; Acsádi G; Dani M
    Acta Paediatr Hung; 1987; 28(2):137-42. PubMed ID: 3122798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-carnitine replacement therapy in chronic valproate treatment.
    Melegh B; Kerner J; Acsádi G; Lakatos J; Sándor A
    Neuropediatrics; 1990 Feb; 21(1):40-3. PubMed ID: 2107456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine disposition before and during valproate therapy in patients with epilepsy.
    Riva R; Albani F; Gobbi G; Santucci M; Baruzzi A
    Epilepsia; 1993; 34(1):184-7. PubMed ID: 8422857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of carnitine and carnitine precursors lysine, epsilon-N-trimethyllysine, and gamma-butyrobetaine in drug-induced carnitine depletion.
    Melegh B; Pap M; Bock I; Rebouche CJ
    Pediatr Res; 1993 Oct; 34(4):460-4. PubMed ID: 8255678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
    Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A
    Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine.
    Kossak BD; Schmidt-Sommerfeld E; Schoeller DA; Rinaldo P; Penn D; Tonsgard JH
    Neurology; 1993 Nov; 43(11):2362-8. PubMed ID: 8232957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation.
    Nishida N; Sugimoto T; Araki A; Woo M; Sakane Y; Kobayashi Y
    Pediatr Res; 1987 Nov; 22(5):500-3. PubMed ID: 3120144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of valproic acid on plasma carnitine levels.
    Opala G; Winter S; Vance C; Vance H; Hutchison HT; Linn LS
    Am J Dis Child; 1991 Sep; 145(9):999-1001. PubMed ID: 1877582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation ofserum free carnitine/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid.
    Kulhas Celik I; Tasdemir HA; Ince H; Celik H; Sungur M
    Clin Neurol Neurosurg; 2018 Jul; 170():106-112. PubMed ID: 29772401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum carnitine during valproic acid therapy.
    Laub MC; Paetzke-Brunner I; Jaeger G
    Epilepsia; 1986; 27(5):559-62. PubMed ID: 3093213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased fasting free fatty acids with L-carnitine in children with carnitine deficiency.
    Schwenk WF; Hale DE; Haymond MW
    Pediatr Res; 1988 May; 23(5):491-4. PubMed ID: 3290828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine deficiency during valproic acid treatment.
    Van Wouwe JP
    Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine deficiency: Risk factors and incidence in children with epilepsy.
    Fukuda M; Kawabe M; Takehara M; Iwano S; Kuwabara K; Kikuchi C; Wakamoto H; Morimoto T; Suzuki Y; Ishii E
    Brain Dev; 2015 Sep; 37(8):790-6. PubMed ID: 25547040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder.
    Yokoyama S; Yasui-Furukori N; Nakagami T; Miyazaki K; Ishioka M; Tarakita N; Kubo K; Sugawara N; Shimoda K
    Ther Drug Monit; 2020 Oct; 42(5):766-770. PubMed ID: 32482992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.